Erratum to: Autoradiography, MALDI-MS, and SIMS-MS Imaging in Pharmaceutical Discovery and Development
Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 1
Abstract
This article was published with incorrect reference citations in the permission notes in the legends for Figures  8 and 9. The permission note for Figure 8 should read: (Adapted with permission from Ref. 84). The permission note for Figure 9 should read: (Adapted with permission from Ref. 85).
Authors and Affiliations
Eric G. Solon, Alain Schweitzer, Markus Stoeckli, Brendan Prideaux
Keywords
Related Articles
- EP ID EP681364
- DOI 10.1208/s12248-009-9167-3
- Views 85
- Downloads 0
Therapeutic Protein Drug–Drug Interactions: Navigating the Knowledge Gaps–Highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA Workshop
The investigation of therapeutic protein drug–drug interactions has proven to be challenging. In May 2012, a roundtable was held at the American Association of Pharmaceutical Scientists National Biotechnology Con...
Role of MRP4 and MRP5 in biology and chemotherapy
Nucleotide efflux (especially cyclic nucleotides) from a variety of mammalian tissues, bacteria, and lower eukaryotes has been studied for several decades. However, the molecular identity of these nucleotide efflux trans...
Aerosol delivery of muramyl dipeptide to rodent lungs
Tuberculosis is the single most serious infectious disease worldwide. The respiratory tract is the primary site of infection by Mycobacterium tuberculosis (MTB). A number of immunogenic components of the cell wall of MTB...
Pharmacodynamics of Telomerase Inhibition and Telomere Shortening by Noncytotoxic Suramin
We reported that suramin is an effective chemosensitizer at noncytotoxic concentrations (<50 μM); this effect was observed in multiple types of human xenograft tumors in vitro and in vivo. Clinical evalua...
Workshop Report: Crystal City V—Quantitative Bioanalytical Method Validation and Implementation: The 2013 Revised FDA Guidance
In September 2013, the FDA released a draft revision of the Bioanalytical Method Validation (BMV) Guidance, which included a number of changes to the expectations for bioanalysis, most notably the inclusion of biomarker...